Genprex raises ~$3.4M in registered direct offering plus up to $6.6M from warrant exercise

Genprex, Inc.

Offering: 377,780 shares at $9.00/share; gross proceeds ~$3.4M before fees.
Concurrent private placement of warrants for 755,560 shares at $8.75 exercise price.
Warrants expire 24 months from effective date of resale registration statement.
Net proceeds expected ~$3.0M; use for working capital and general corporate purposes.
Closing expected on or about Oct 29, 2025; H.C. Wainwright as placement agent.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Genprex, Inc. issued up to an aggregate of 755,560 shares of Common Stock of warrant to certain investors named therein (the "Purchasers").

Security: warrant
Shares: up to an aggregate of 755,560 shares of Common Stock
Purchaser: certain investors named therein (the "Purchasers")

Exact text from the filing

the Company agreed to issue to the Purchasers warrants (the "Private Warrants") exercisable for up to an aggregate of 755,560 shares of Common Stock (the "Private Warrant Shares")

View on SEC.gov

52 equity issuances filed in the last 30 days. Browse all equity issuances →

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-032081

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.